ng-nitroarginine methyl ester has been researched along with Heritable Pulmonary Arterial Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, Y; Morita, T; Nagai, R; Sahara, M; Sata, M | 1 |
| Baelde, HJ; de Visser, YP; Laghmani, el H; Sengers, RM; Steendijk, P; Wagenaar, GT; Walther, FJ | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Heritable Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
Topics: Animals; Antihypertensive Agents; Apoptosis; Blotting, Western; Caspase 3; Cells, Cultured; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Familial Primary Pulmonary Hypertension; Glyburide; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Pulmonary; Injections, Intraperitoneal; Male; MAP Kinase Signaling System; Monocrotaline; NG-Nitroarginine Methyl Ester; Nicorandil; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Pressure | 2012 |
Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury.
Topics: Animals; Animals, Newborn; Familial Primary Pulmonary Hypertension; Heart; Hyperoxia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; NG-Nitroarginine Methyl Ester; Phenylpropionates; Pulmonary Alveoli; Pyridazines; Rats; Time Factors | 2013 |